Effect of Cigarette Smoke Exposure on MPTP Metabolism in the Liver of Mice

  • Heung Bin Lim (Laboratory of Biochemistry) ;
  • Ja Young Moon (Laboratory of Biochemistry, Korea Ginseng and Tobacco Research Institute) ;
  • Hyung Ok Sohn (Laboratory of Biochemistry, Korea Ginseng and Tobacco Research Institute) ;
  • Young Gu Lee (Laboratory of Biochemistry, Korea Ginseng and Tobacco Research Institute) ;
  • Dong Wook Lee (Laboratory of Biochemistry, Korea Ginseng and Tobacco Research Institute)
  • 발행 : 1998.06.01

초록

Numerous studies have demonstrated a negative association between cigarette smoking and Parkinson's disease. The present study was undertaken to investigate whether chronic exposure of mice to cigarette smoke a(footed the metabolism of 1-methyl-1113,6-tetrahydro-pyridine (MPTP) by cytochrome P4SO (P-450) or flavin-containing monooxygenase (FMO) in the hepatic microsomes of C57BL6/J mice. Adult male C57BL6/J mice were exposed to mainstream smoke generated from 15 cigarettes for 10 min a day and 5 day per week for 6 weeks. MPTP (10 mg/kg body weight) was administered to mice by subcutaneous injection for 6 consecutive days. Microsolnal P-450 content was increased by MPTP, smoke exposure, or both, but NADPH cytochrome P-450 reductase activity was rather decreased by the same treatments. The activities of benzo(a)pyrene hydroxylase, 7-ethoxycoumarin O-deethylase and ethoxyresorufin O-deethylase were significantly increased by the exposure of cigarette smoke, but were not or little affected by MPTP treatment. Benzphetamine N-demethylase activity was not affected either by MPTP treatment or by cigarette smoke exposure, but it was significantly increased by the combined MPTP treatment with cigarette smoke exposure, showing their synergic effect for the induction of the enzyme activity. Interestingly, in vitro studies of hepatic FMO and P-450 system both O-oxygenation and N-demethylation of MPTP were increased in the smoke-exposed or in the MPTP-treated mice. These results suggest that the enhancement in the N-demethylation as well as O-deethylation of P-450 system and in the N-oxygenation of FMO activity by cigarette smoke exposure in mouse liver may contribute to attenuating the neurotoxic effects of MPTP on the nigrostriatal dopaminergic neurons.

키워드

참고문헌

  1. Neurology v.35 Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydopyridine(MPTP): Seven cases Ballard, P.A.;Tetrud, J.W.;Langsron, J.W.
  2. Effects of Nicotine on Biological System Ⅱ The epidemiology of cigarette smoking and Parkinson's disease Baron, J.A.;Clarke PBS;Quik M;Adlkofer F;Thurau-K(eds.)
  3. Drug Metab. Dispos v.5 Characteristics of a microsomal cytochrome P-448-mediated reaction. Ethoxyresorufin O-deethylase Burke, M.D.;Prough, R.A.;Mayer, R.T.
  4. Neuropharmacology v.29 Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke Carr, L.A.;Rowell, P.P
  5. Mol. Pharmacol v.29 Contribution of N-oxygenation of the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations Cashman, J.R.;Ziegler, D.M.
  6. J. Pharmacol. Exp. Ther. v.246 Characterization of hepatic microsomal metabolism as an vivo detoxification patyway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice Chiba, K.;Kubota, E.;Miyakawa, R.;Kato, Y.;Ishizaki, T>
  7. Biochem, Pharmacol v.33 Promary arylamine oxidation by flavin-hydroperoxide: A study of the basis for the substrate specificity of the flavoprotein monooxygenase Doerge, D.R.;Corbett, M.D.
  8. Biochem. Biophys. Res. Commun v.148 MPTP, the meurotoxin inducing Parkinsons's disease, is a potent competitive inhibitor if human and rat cytochrome P-450 isozymes(P-450bufI, P450db1) catalyzing debrisoquine 4-hydroxylation Fonne-Pfister, R.;Bargetzi, M.J.;Meyer, U.A.
  9. J. Pharmacol v.208 MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease Gerlach, M.;Riederer, P.;Przuntek, H.;Youdim, M.B.H.
  10. Drug Metab. Rev v.26 Role of humans cytochromes P450 in the metabolic activation of chemical carcinogens and toxins Gonzalez, F.J.;Gelboin, H.V.
  11. Am. J. Epidemiol v.139 Prospectibe study of cigarette smoking and the risk of developing idiopathic Parkinsons disease Grandinetti, A.;Morens, D.M.;Reed, D.;MacEachem, D.
  12. J. Pharmacol. Exp. Ther v.205 An improved assay of 7-ethoxycoumarin O-deethylase activity. Induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methycholanthrene and 2,3,7,8-tetra-chlorodibenzo-p-dioxin Greenlee, W.F.;Poland, A.
  13. Neuroepidemiology v.12 Induction of cytochrome P-450 enzymes via tobacco smoke: A potential mechanism for developing resistance to environmental toxins as related to Parkinsonism and other neurologic diseases Gresham, L.S.;Molgaard, C.A.;Smith, R.A.
  14. J. Biol. Chem. v.270 The stoichiometry of the cytochrome P-450-catalyzed metabolism of methoxyflurane and benzphetamine in the presence and absence of cytochrome b5 Gruenke, L.D.;Konopka, K.;Cadieu, M.;Waskell, L.
  15. Arch. Biochem. Biophys v.310 Differential roles of Glu318 and Thr319 in cytochrome P450 1A2 catalysis supported by NADPH-cytochrome P450 reductase and tert-butyl hydroperoxide Hiroya, K.;Murakami, Y.;Shimizu, T.;Hatano, M.;Ortiz de Montellano, P.R.
  16. J. Neurol. Sci v.121 Correspondence of increased debrisoquine 4-monooxygenase activity with seizure-susceptibility in Mongolian gerbils Iwahashi, K.;Suwaki, H.;Matsuo, Y.;Ichikawa, Y.;Hosokawa, K.
  17. Ann. Rev. Neurosci v.11 MPTP toxicity: Implications for research in Parkinson's disease Kopin, I.J.
  18. J. Kor. Soc. Tobac. Sci v.18 Effect of cigarette smoke exposure on MPTP-induced neurotoxicity in mice Lim, H.B.;Sohn, H.O.;Lee, Y.G.;Lee, D.W.
  19. Kor. J. Gerontol v.7 Effect of food restriction o agerelated changes of liver microsomal cytochrome P-450 system Lim, H.B.;Sohn, H.O.;Lee, Y.G.;Lee, D.W.
  20. Proceeding of the Sociely for Research on Nocotine and Tobacco, 3rd annual meeting Protection of MPTP neurotixicity by cigarette smoke and its possible mechanism Moon, J.Y.;Lim, H.B.;Sohn, H.O.;Lee, Y.G.;Kang, Y.K.;Lee, D.W.
  21. Xenobiotica v.38 Inhibition of 7-ethoxycomarin O-deethylase activity in rat liver microsomes by naturally occurring flavonoids: structure-activity relationships Moon, J.Y.;Lim, D.W.;Park, K.H.
  22. J. Biol. Chem v.243 Substrateinducible microsomal aryl hydroxylase in mammaliam cell culture Nebert, D.W.;Gelboin, H.V.
  23. DNA Cell Biol v.12 The P450 superfamily: update on new sequence, gene mappingm accession numbers, early trivial names of enzymes, and nomenclature Nelson, D.R.;Kamataki, T.;Waxman, D.J.;Guengerich, F.P.;Estabrook, R.W.;Feyereisen, R.;Gonzalez, F.J.;Coon, M.J.;Gonzalus, I.C.;Gotoh, O.;Okuta, K.;Nebert, D.W.
  24. J. Biol. Chem v.239 The carbon monoxide-bindign pigment of liver microsomes Omura, T.;Sato, R.
  25. Chem. Res. Toxicol v.3 Studies on the cytochrome P-450 catalyzed ring alphacarbon oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP) Ottoboni, S.;Carlson, T.J.;Trager, W.F.;Castagnoli, K.;Castagnoli, Jr., N.
  26. Brain Res v.555 Protection and potentiation of MPTP-induced toxicity by cytochrome P-450 inhibitors and inducer: in vitro studies with brain slices Pai, K.S.;Ravindranath, V.
  27. Br. J. Clin. Pharmacol v.22 The effect of cogarette smoking on 7-ethoxyresorufin O-deethylase and other monooxygenase activities in human liver: analysis with monoclonal antibodies Pelkonen, O.;Pasanen, M.;Kuha, H.;Gachalyi, B.;Kairaluoma, M.;Sotaniemi, E.A.;Park, S.S.;Friedman, F.K.;Gelboin, H.V.
  28. FASEP J. v.6 A parkinsonian syndrome induced in the goldfish by the neurotoxin MPTP Pollard, H.B.;Dhariwai, K.;Adeyemo, O.M.;Markey, C. J;Caohuy, H.;Levin. M.;Markey, S.;Youdium, M.B.H
  29. Biochem. Biophys. Res. Commun v.219 High inducibility of mouse renal CYP2E1 gene by tabacco smoke and its possible effect on DNA single strand breaks Seree, E.M.;Villiard, P.H.;Re, J.L.;De Meo, M.;Lacarelle, B.;Attolini, L.;Dumenil, G.;Catalin, J.;Duran, A.;Barra, Y.
  30. Proc. BPERC Int. Symp Investigation of monoamine oxidase B inhibitor: A potential antiparkinsonian drug Sohn, H.O.;Lin, H.B.;Moon, J.Y.;Lee, Y.G.;Kang, Y.K.;Lee, D.W.
  31. J. Biol. Chem v.251 Multiple forms of rat liver cytochrome P-450. Immunochemical evidence with antibody against cytochrome P-448 Thomas, P.E.;Lu, A.Y.H.;Ryant, D.;West, S.B.;Kawarek, J.;Levin, W.
  32. Toxicol. Appl. Pharmacol. v.148 Effects of tobacco smoke on the gene expression of the CYP1a, CYP2b, CYP2e, and CYP3a subfamiles in mouse liver and lung: relation to single strand breaks of DNA Villard, P.H.;Seree, E.M.;RE, J.L.;Meo, M.D.;Barra, Y.;Attolini, L.;Dumenil, G.;Catalin, J.;Durand, A.;Lacarelle, B.
  33. J. Biol. Chem v.237 Microsomal triphosphopuridine nucleotidecytochrome C reductase of liver Williams, C.H. Jr.;Kamin, M.
  34. Biochem. Pharmacol v.44 Neurotoxins: 1-methyl-1,2,3,6-tetrahydropyridine, 1,2,3,4-tetrahydroisoquinoline and 1-methyl 6,7-dihydroxy-tetrahydro-isoquinoline as substrates for FAD-containing monooxygenase of porcine liver microsomes Wu, R.F.;Miura, S.;Ichikawa, Y.
  35. Biochim. Biophys. Acta v.1208 Characteristic properties and kinetic analysis with neurotoxins of porcine FAD-containing monooxygenase Wu, R.F.;Lchikawa, Y.
  36. FEBS v.358 Inhibitionof 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolic activity of poicine FAD-containing monooxygenase by selective monoamine oxidase-B inhibitors Wu. R.F.;Ichikawa, Y.
  37. Biochemistry v.34 Roles of divalent metal iones in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH-cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates Yamazaki, H.;Ueng, Y.F.;Shimada, T.;Guengerich, F.P.